Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16 E7 oncoprotein

Gynecologic Oncology

Volumn 122, Issue 2, 2011, Pages 430-436

  Liu, Juan ^a   Wang, Xiao ^a   Zhou, Gengyin ^a   Wang, Hong ^a   Xiang, Lei ^a   Cheng, Yizhe ^a   Liu, Wenjun ^a   Wang, Yan ^a   Jia, Jihui ^a   Zhao, Weiming ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Cancerous inhibitor of protein phosphatase 2A; Cervical cancer; Human papillomavirus E7

Indexed keywords

CANCEROUS INHIBITOR OF PROTEIN PHOSPHATASE 2A; INHIBITOR PROTEIN; MYC PROTEIN; ONCOPROTEIN; PROTEIN E7; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL ANCHORAGE; CELL GROWTH; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TISSUE DISTRIBUTION; TUMOR PROMOTION; UPREGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; WESTERN BLOTTING;

AUTOANTIGENS; CELL LINE, TUMOR; FEMALE; GENES, MYC; HUMANS; MEMBRANE PROTEINS; PAPILLOMAVIRUS E7 PROTEINS; RNA, MESSENGER; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 79960467126     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.04.031     Document Type: Article

References (30)

1. T. Yugawa, and T. Kiyono Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins Rev Med Virol 19 2 2009 97 113
2. P.J. Snijders, R.D. Steenbergen, D.A. Heideman, and C.J. Meijer HPV-mediated cervical carcinogenesis: concepts and clinical implications J Pathol 208 2 2006 152 164 Review. (Pubitemid 43126109)
3. J.M. Walboomers, M.V. Jacobs, and M.M. Manos Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19 (Pubitemid 29406813)
4. K. Münger, A. Baldwin, and K.M. Edwards Mechanisms of human papillomavirus-induced oncogenesis J Virol 78 21 2004 11451 11460 (Pubitemid 39390733)
5. J. Bodily, and L.A. Laimins Persistence of human papillomavirus infection: keys to malignant progression Trends Microbiol 19 1 2011 33 39
6. T. Yugawa, and T. Kiyono Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins Rev Med Virol 19 2 2009 97 113
7. M.R. Junttila, P. Puustinen, and M. Niemela CIP2A inhibits PP2A in human malignancies Cell 130 2007 51 62 (Pubitemid 47039258)
8. W. Li, Z. Ge, and C. Liu CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells Clin Cancer Res 14 2008 3722 3728
9. C. Côme, A. Laine, and M. Chanrion CIP2A is associated with human breast cancer aggressivity Clin Cancer Res 15 16 2009 5092 5100
10. J. Katz, A. Jakymiw, and M.K. Ducksworth CIP2A expression and localization in oral carcinoma and dysplasia Cancer Biol Ther 10 7 2010 694 699
11. Q.Z. Dong, Y. Wang, and X.J. Dong CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis Ann Surg Oncol 18 3 2011 Mar 857 865
12. D. Zhao, Z. Liu, and J. Ding Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways J Med Microbiol 59 2010 259 265
13. M. Arroyo, S. Bagchi, and P. Raychaudhuri Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex Mol Cell Biol 13 1993 6537 6546 (Pubitemid 23292648)
14. K. Zerfass-Thome, W. Zwerschke, B. Mannhardt, R. Tindle, J.W. Botz, and P. Jansen-Durr Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16, E7 oncoprotein Oncogene 13 1996 2323 2330
15. D. Pim, P. Massimi, S.M. Dilworth, and L. Banks Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A Oncogene 24 2005 7830 7838 (Pubitemid 41715189)
16. A. Brehm, S.J. Nielsen, and E.A. Miska The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth EMBO J 18 1999 2449 2458 (Pubitemid 29213278)
17. M. Narisawa-Saito, and T. Kiyono Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins Cancer Sci 98 10 2007 1505 1511 (Pubitemid 47308443)
18. P.J. Koskinen, and K. Alitalo Role of myc amplification and overexpression in cell growth, differentiation and death Semin Cancer Biol 4 1 1993 3 12
19. P.J. Hurlin, and S. Dezfouli Functions of myc:max in the control of cell proliferation and tumorigenesis Int Rev Cytol 238 2004 183 226 (Pubitemid 39201316)
20. D. Xu, N. Popov, and M. Hou Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells Proc Natl Acad Sci U S A 98 7 2001 3826 3831 (Pubitemid 32249856)
21. L.M. Facchini, and L.Z. Penn The molecular role of Myc in growth and transformation: recent discoveries lead to new insights FASEB J 9 1998 633 651 (Pubitemid 28247143)
22. M. Donzelli, R. Bernardi, and C. Negri Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene Oncogene 18 2 1999 439 448 (Pubitemid 29060619)
23. A. Albihn, J.I. Johnsen, and M.A. Henriksson MYC in oncogenesis and as a target for cancer therapies Adv Cancer Res 107 2010 163 224
24. C. Aoyama, J. Peters, S. Senadheera, P. Liu, and H. Shimada Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction Diagn Mol Pathol 7 6 1998 324 330 (Pubitemid 29177575)
25. S.A. Nair, M.B. Nair, P.G. Jayaprakash, T.N. Rajalekshmy, M.K. Nair, and M.R. Pillai ras and c-myc oncoproteins during tumor progression in the uterine cervix Tumori 84 5 1998 583 588
26. T. Iwasaka, M. Yokoyama, and M. Oh-uchida Detection of human papillomavirus genome and analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinomas Gynecol Oncol 46 3 1992 298 303
27. J. Bourhis, M.G. Le, and M. Barrois Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix J Clin Oncol 8 11 1990 1789 1796 (Pubitemid 20382340)
28. A. Zhang, S. Maner, and R. Betz Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection Int J Cancer 101 2002 427 433
29. M.C. Abba, R.M. Laguens, F.N. Dulout, and C.D. Golijow The c-myc activation in cervical carcinomas and HPV 16 infections Mutat Res 557 2 2004 151 158 (Pubitemid 38068555)
30. P. Münzel, D. Marx, H. Köchel, A. Schauer, and K.W. Bock Genomic alterations of the c-myc proto-oncogene in relation to the overexpression of c-erbB2 and Ki-67 in human breast and cervix carcinomas J Cancer Res Clin Oncol 117 6 1991 603 607